Agonists for antimicrobial peptide systems
Short chain fatty acids (SCFAs) and glycerol esters of SCFAs not previously used for that purpose are provided for use as a medicament for treating, preventing or counteracting microbial infections in animals, including humans, by stimulating the innate antimicrobial peptide defense system. Preferred compounds include phenyl substituted short chain fatty acids (SCFAs) derivatives and. Also provided are methods and compositions for treating, preventing or counteracting microbial infections, including bacterial, viral, fungal, and parasitic infections, by administration of medicaments comprising a secretagogue-effective amount of the compounds of the invention.
1. A method of treating a microbial infection in an animal by stimulating the innate antimicrobial peptide defense system, the method comprising administering to the animal a medicament comprising a compound,
wherein the compound is 4-phenylbutyric acid and
wherein the infection is a bacterial infection caused by a microbial species selected from the group consisting of Shigella and E. Coli.
2. The method of claim 1 , wherein the medicament comprises the compound in an amount of 1 g to 10 g daily.
3. The method of claim 1 , wherein the medicament is a pharmaceutical composition comprising a unit dose of the compound in the range of about 10-1000 mg and at least one pharmaceutically acceptable excipient, wherein the dose is administered daily.
4. The method of claim 1 , wherein the medicament is administered in the treatment at less than 720 mg daily.
5. The method of claim 1 , wherein the infection is a bacterial infection caused by Shigella.
6. The method of claim 1 , wherein the infection results in a gastrointestinal disorder selected from the list consisting of traveller's diarrhoea, and endemic diarrhoea.
7. The method of claim 1 , wherein the infection is an infection of the respiratory system.
8. The method of claim 1 , wherein the method is a combination method for treating the microbial infection in the animal, wherein the compound is used in combination with any one or more of: an antibiotic; an aminosterol-type compound; isoleucine or active isomers or analogs thereof; or a vitamin D type compound.
9. The method of claim 8 , wherein the compound is used in combination with vitamin D.
10. The method of claim 1 , wherein the medicament is in an oral dosage form.
11. The method of claim 1 , wherein the animal is a human.
12. The method of claim 1 , wherein the medicament is administered orally.